• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Fibrinolytic system in atherosclerosis.

作者信息

Balkuv-Ulutin S

出版信息

Semin Thromb Hemost. 1986 Apr;12(2):91-101. doi: 10.1055/s-2007-1003541.

DOI:10.1055/s-2007-1003541
PMID:3738530
Abstract

In this short review I have tried to report the literature findings and describe some of our observations on fibrinolysis and atherosclerosis. Although at this time it is difficult to state that diminished FA plays a pathogenic role in atherosclerosis, it certainly seems to represent a risk factor.

摘要

相似文献

1
Fibrinolytic system in atherosclerosis.
Semin Thromb Hemost. 1986 Apr;12(2):91-101. doi: 10.1055/s-2007-1003541.
2
Concepts of clot lysis.血栓溶解的概念。
Annu Rev Med. 1986;37:187-204. doi: 10.1146/annurev.me.37.020186.001155.
3
[Tissue plasminogen activator: mechanism of action and thrombolytic properties].[组织型纤溶酶原激活剂:作用机制及溶栓特性]
Sangre (Barc). 1984;29(4-C):767-73.
4
Fibrinolysis: molecular mechanism and pathophysiological aspects.纤维蛋白溶解:分子机制与病理生理学方面
Sangre (Barc). 1984;29(4-C):755-61.
5
Molecular basis of fibrinolysis, as relevant for thrombolytic therapy.与溶栓治疗相关的纤维蛋白溶解的分子基础。
Thromb Haemost. 1995 Jul;74(1):167-71.
6
Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients.纤维蛋白溶解与凝血抑制的病理生理学及临床方面。特别针对口服避孕药的女性和特定血栓易患人群的实验与临床研究。
Dan Med Bull. 1988 Feb;35(1):1-33.
7
[Therapeutic advances against thromboembolic disease: II. The use of tissue fibrinolysis activator as a thrombolytic agent].[抗血栓栓塞性疾病的治疗进展:II. 组织纤维蛋白溶解激活剂作为溶栓剂的应用]
Sangre (Barc). 1984;29(4-A):429-48.
8
Atherosclerosis and hemostasis.动脉粥样硬化与止血
Semin Thromb Hemost. 1986 Apr;12(2):156-74. doi: 10.1055/s-2007-1003546.
9
On the regulation and control of fibrinolysis. Edward Kowalski Memorial Lecture.论纤维蛋白溶解的调控。爱德华·科瓦尔斯基纪念讲座。
Thromb Haemost. 1980 Jun 18;43(2):77-89.
10
[Dysfunction of fibrinolysis as a risk factor of thrombosis].[纤维蛋白溶解功能障碍作为血栓形成的危险因素]
Pol Merkur Lekarski. 2009 Oct;27(160):341-5.